Re-irradiation in Glioblastoma Multiforme

Reirradiation in GBM

Authors

  • Bansal A Associate Professor, Deptt. of Radiation Oncology, Govt. Medical College, Rajindra Hospital, Patiala
  • Banipal RPS Professor and Head Department of Radiation Oncology, Govt. Medical College, Rajindra Hospital, Patiala

Keywords:

Reirradiation, Image guided radiotherapy IGRT, Glioblastoma multiforme

Abstract

This review article addresses the role of re-irradiation in recurrent cases of previously treated Glioblastoma multiforme (GBM). The article particularly focuses on patient selection, imaging, dose fractionation regimens, radiation delivery techniques and follow up assesement, survival benefits and toxicities, when re-irradiation is used to treat local recurrences.

Downloads

Download data is not yet available.

References

1. Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al.Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–996.

2. Rades D, Witteler J, Leppert J, Schild SE. Re-irradiation for recurrent glioblastoma multiforme. Anticancer Research. 2020;40(12):7077-81.

3. Dobi, Á., Darázs, B., Fodor, E., Cserháti, A., Együd, Z., Maráz, A., et al. Low fraction size Re-irradiation for large volume recurrence of glial tumours. Pathology & Oncology Research, 2020; 26 :2651-58.

4. G Minniti, C Scaringi, A Arcella, G Lanzetta, D Di Stefano, S Scarpino et al. Hypofractionated stereotactic radiotherapy and bevacizumab in patients with recurrent glioblastoma. J Neurooncol. 2014;118(2):377–383.

5. Gutin PH, Iwamoto FM, Beal K, Mohile NA, Karimi S, Hou BL et al. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2009;75(1):156–63.

6. Minniti G, Niyazi M, Alongi F, Navarria P, Belka C. Current status and recent advances in reirradiation of glioblastoma. Radiat Oncol (London, England) 2021; 16:36.

7. Niyazi M, et al. Re-irradiation in recurrent malignant glioma: retrospective analysis of 198 patients. Clin Oncol (R Coll Radiol). 2014;26(9):563–569.

8. Andratschke, N., Heusel, A., Albert, N.L., Alongi, F., Baumert, B.G., Belka, et al. ESTRO/EANO recommendation on reirradiation of glioblastoma. Radiotherapy and Oncology.2025;204: p.110696.

9. Cabrera AR, Kirkpatrick JP, Fiveash JB, Shih HA, Koay EJ, Lutz S, et al. Radiation therapy for glioblastoma: executive summary of an American Society for Radiation Oncology evidence-based clinical practice guideline. Practical radiation oncology. 2016 ;6(4):217-25.

10. Tsien CI, Pugh SL, Dicker AP, Raizer JJ, Matuszak MM, Lallana EC, et al. NRG oncology/RTOG1205: a randomized phase II trial of concurrent bevacizumab and reirradiation versus bevacizumab alone as treatment for recurrent glioblastoma. J Clin Oncol 2023;41:1285–95.

11. Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010;28(11):1963-1972.

12. Miwa K, Matsuo M, Ogawa S-I, Shinoda J, Yokoyama K, Yamada J, et al. Re- irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/ MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy. Radiat Oncol 2014;9:181.

13. Chapman CH, Hara JH, Molinaro AM, Clarke JL, Bush NAO, Taylor JW, et al. Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival. Neuro-Oncol Pract 2019;6:364–74.

14. Kirkpatrick JP, van der Kogel AJ, Schultheiss TE. Radiation dose-volume effects in the spinal cord. Int J Radiat Oncol Biol Phys 2010;76:S42–9.

15. Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 2010;76(3):S3-9.

16. Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Medical physics. 2010 Aug;37(8):4078-101.

17. Minniti G, Armosini V, Salvati M, Lanzetta G, Caporello P, Mei M, et al. Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma. J Neuro-Oncol 2012;103:683–91.

18. Christ SM, Youssef G, Tanguturi SK, Cagney D, Diana Shi J, McFaline-Figueroa R, et al. Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: target delineation, outcomes and patterns of recurrence. Clin Transl Radiat Oncol 2024;44:100697

19. Kazmi F, Soon YY, Leong YH, Koh WY, Vellayappan B. Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis. Journal of neuro-oncology. 2019 ;142:79-90.

Downloads

Published

01-01-2026

How to Cite

Bansal, A., & Banipal, R. P. S. (2026). Re-irradiation in Glioblastoma Multiforme: Reirradiation in GBM. GMC Patiala Journal of Research and Medical Education, 8(02), 29–35. Retrieved from https://jrme.gmcpatiala.edu.in/index.php/j/article/view/206

Issue

Vol. 8 No. 02 (2025): JUL-DEC

Section

Review Article

License

Copyright (c) 2026 Bansal A, Banipal RPS

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.